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ABSTRACT
We have previously investigated the relative roles of
extracellular glucose and lactate as fuels for glutamatergic
neurons during synaptic activity. The conclusion from these
studies was that cultured glutamatergic neurons utilize
glucose rather than lactate during NMDA (N-methyl-D-
aspartate)-induced synaptic activity and that lactate alone
is not able to support neurotransmitter glutamate
homoeostasis. Subsequently, a model was proposed to
explain these results at the cellular level. In brief, the
intermittent rises in intracellular Ca
2+ during activation
cause influx of Ca
2+ into the mitochondrial matrix thus
activating the tricarboxylic acid cycle dehydrogenases. This
will lead to a lower activity of the MASH (malate–aspartate
shuttle), which in turn will result in anaerobic glycolysis
and lactate production rather than lactate utilization. In
the present work, we have investigated the effect of an
ionomycin-induced increase in intracellular Ca
2+ (i.e.
independent of synaptic activity) on neuronal energy
metabolism employing
13C-labelled glucose and lactate and
subsequent mass spectrometric analysis of labelling in
glutamate, alanine and lactate. The results demonstrate
that glucose utilization is positively correlated with
intracellular Ca
2+ whereas lactate utilization is not. This
result lends further support for a significant role of glucose
in neuronal bioenergetics and that Ca
2+ signalling may
control the switch between glucose and lactate utilization
during synaptic activity. Based on the results, we propose a
compartmentalized CiMASH (Ca
2+-induced limitation of
the MASH) model that includes intracellular compartmen-
tation of glucose and lactate metabolism. We define pre-
and post-synaptic compartments metabolizing glucose and
glucose plus lactate respectively in which the latter displays
a positive correlation between oxidative metabolism of
glucose and Ca
2+ signalling.
Key words: Ca
2+, glucose, lactate, malate–aspartate shuttle
(MASH), neuron.
INTRODUCTION
The main energy substrate for the brain is undoubtedly
glucose, but whether glucose itself or glucose-derived lactate
produced by nearby astrocytes is the preferred energy
substrate for glutamatergic neurons during activation has
been debated in recent years (for a recent review, see Dienel,
2011). The astrocyte–neuron lactate shuttle hypothesis
suggests that during brain activation, astrocytes metabolize
blood–borne glucose to lactate, which is then released and
metabolized by nearby glutamatergic neurons during activa-
tion (Pellerin and Magistretti, 1994; Pellerin et al., 2007).
Lactate is beyond any doubt an important (energy) substrate
for neurons both in vitro and in vivo; most recently, it has
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derived) lactate is important for memory formation (Newman
et al., 2011; Suzuki et al., 2011); however, neurons in vivo
may consume as much as 65% of the interstitial glucose
(Zielke et al., 2007). We have previously shown that mouse
cerebellar (glutamatergic) neurons in culture metabolize
lactate avidly; however, utilization of glucose but not that
of lactate was increased during NMDA (N-methyl-D-aspar-
tate)-induced synaptic activity and, furthermore, lactate
alone was not able to support neurotransmitter homoeostasis
in these cells (Bak et al., 2006). Since synaptic activity is
associated with an increase in the [Ca
2+]i (intracellular
concentration of Ca
2+), a central regulator of key metabolic
processes, we have previously proposed a model (Bak et al.,
2009) in which Ca
2+, after entry into the mitochondrial
matrix, partially inhibits (i.e. limits the maximal activity) the
MASH (malate–aspartate shuttle). This shuttle is believed to
be of crucial importance for net transport of reducing
equivalents across the inner mitochondrial membrane
(McKenna et al., 2006). Such limitation of MASH activity
increases cytosolic NADH and favours production of lactate
and consumption of glucose via anaerobic glycolysis whereas
utilization of lactate would be repressed. When the level of
[Ca
2+]i returns to resting levels between action potentials, the
MASH would be reactivated causing a decrease in cytosolic
NADH and both glucose and lactate may then be metabolized.
The net result of this is that utilization of glucose increases
with synaptic activity [see Figure 1 and Bak et al. (2009) for
further details]. In the following, we will refer to this model
as the CiMASH (Ca
2+-induced limitation of the MASH) model.
The previous work (Bak et al., 2006, 2009) was performed by
inducing synaptic activity employing pulses of NMDA. In the
present work, we aimed to investigate the effect of an
isolated increase in [Ca
2+]i (i.e. independent of synaptic
activity) on neuronal utilization of glucose and lactate. To
this end, we incubated cultured mouse cerebellar neurons
[CCNs (cultured cerebellar neurons)] in the presence of
[U-
13C]glucose (2.5 mM), [U-
13C]lactate (1.0 mM), and the
combined presence of both substrates with only one of them
labelled. Intracellular [Ca
2+] was titrated employing ionomy-
cin, and
13C labelling in intracellular glutamate, alanine and
lactate was analysed by MS. The results suggest that
utilization of glucose correlates positively with increasing
[Ca
2+]i, whereas lactate shows no such correlation; this
indicates that intracellular Ca
2+ signalling in neurons
promotes utilization of glucose as energy substrate.
MATERIALS AND METHODS
Materials
Seven-day-old NMRI mice were acquired from Taconic M&B.
Plastic culture flasks were purchased from NUNC A/S. Corning
cellBIND surface 96-well plates as well as culture medium,
poly-D-lysine (Mw.300 kg/mol), ionomycin, MTBSTFA (N-
tertbutyl-dimethylsilyl-N-methyltrifluoroacetamide) contain-
ing 1% tertbutyl-dimethylchlorosilane were from Sigma–
Aldrich. Fetal calf serum was purchased from Seralab Ltd,
[U-
13C]glucose and [U-
13C]lactate from Cambridge Isotope
Laboratories and penicillin from Leo Pharma. Fura 2/AM (fura
2 acetoxymethyl ester) was obtained from Invitrogen A/S. All
other chemicals were of the purest grade available from
regular commercial sources.
Cell culture
Primary cultures of murine cerebellar granule (glutamatergic)
neurons (CCNs) were prepared as described previously
(Schousboe et al., 1989). Briefly, cerebellum was excised
from 7-day-old animals. The tissue was finely chopped,
subjected to a gentle trypsinization (0.25 mg/ml trypsin for
15 min at 37˚C) and triturated in a solution containing DNase
[75 i.u. (international units)/ml] and trypsin inhibitor
(0.53 mg/ml). The resulting cells were suspended in a
modified Dulbecco’s medium containing 24.5 mM KCl,
12 mM glucose, 7 mM p-aminobenzoate, 50 mM kainate
and 10% (v/v) fetal calf serum to a total concentration of
2.75610
6 cells/ml and seeded in poly-D-lysine coated 25 cm
2
culture flasks (5 ml per flask) or to a total concentration of
2.5610
6 cells/ml for seeding in poly-D-lysine coated 96-well
plates (100 ml per well). The cultures were kept in a
humidified atmosphere containing 5% CO2 at 37˚C and
employed for experiments after 7–8 days in vitro. In order to
prevent astrocyte proliferation, cytosine arabinoside was
added to a final concentration of 20 mM after 48 h in culture.
Moreover, glucose was supplemented twice during culturing
to ensure a minimum concentration of 12 mM. The presence
of kainate blocks functional development of the subpopula-
tion of GABAergic neurons (Drejer and Schousboe, 1989;
Sonnewald et al., 2004, 2006) and its combination with
cytosine arabinoside results in cultures containing 80–90%
neurons exhibiting glutamatergic characteristics. Animals
were handled according to Danish law and university policy
under which no ethical approval is needed for the work
carried out in this project.
Measurement of relative intracellular Ca
2+ levels
The [Ca
2+]i response to increasing concentrations of ionomy-
cin was measured using the ratiometric Ca
2+ probe fura-2
(Grynkiewicz et al., 1985). Cerebellar neurons seeded in 96-
well plates were loaded by adding 5.2 mM fura-2/AM to the
culture medium and incubating for 45 min in a humidified
atmosphere containing 5% CO2 at 37˚C. The cells were
washed once with a Tris-buffered saline solution (15 mM Tris/
HCl, 1 mM MgSO4, 140 mM NaCl, 3.5 mM KCl, 1.8 mM CaCl2,
5 mM glucose and 1.2 mM Na2PO4, pH 7.4) and left at room
temperature (20˚C) for 5 min to ensure complete de-
esterification. The cultures were then incubated in a buffer
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0.5 or 0.75 mM ionomycin for 30 min. During both the de-
esterification period and the experiment 10 mM of MK-801
and 30 mM verapamil were present in order to eliminate
contributions from NMDA receptor stimulation (from any
transmitter glutamate released due to the elevated [Ca
2+]i)
and L-type voltage-gated Ca
2+ channels respectively.
Employing a NOVOstar plate reader (BMG LABTECH GmbH),
Figure 1 The CiMASH mechanism in glutamatergic neurons as originally described in Bak et al. (2009)
(A) Schematic depiction of a neuron showing possible mechanisms involved in regulation of glucose (glc) and lactate (lac)
metabolism during neuronal depolarization and (B) the dynamics of glucose and lactate metabolism during re-polarization and at
resting membrane potential. (C) A schematic depiction of cytosolic Ca
2+ dynamics during neuronal spiking; arrows indicate when the
CiMASH mechanism is operating. During neuronal depolarization (A), [Ca
2+]i is increased via flux of Ca
2+ through NMDA receptors
and voltage-gated Ca
2+ channels (VGCC) subsequently inducing release from endoplasmic reticulum (ER, 1). This triggers
accumulation of Ca
2+ in the mitochondrial matrix (2) and activation of a-ketoglutarate dehydrogenase (a-KGDH, 3), which competes
with the malate/a-ketoglutarate carrier (MKC) for substrate thus limiting efflux of a-ketoglutarate (a-KG, 4). This leads to less a-
ketoglutarate being available for the cytosolic aspartate aminotransferase (AATc) reaction (5) in turn limiting activity of cytosolic
malate dehydrogenase (MDHc) and thus re-oxidation of cytosolic NADH (6). The increased cytosolic [NADH] together with decreased
[ATP] will activate anaerobic glycolysis leading to lactate synthesis via the LDH reaction and re-oxidation of NADH (7). During
this period, oxidation of lactate will be limited because of the increased [NADH] (8, 9). (B) During neuronal re-polarization and in the
period between depolarizations where [Ca
2+]i is low and MASH activity is restored, cytosolic [NAD
+] will increase again. In
conjunction with the increased [lactate] formed by anaerobic glycolysis, this will limit formation of lactate via the LDH reaction (10)
whereas the opposite reaction is now favoured (11). The net effect at this point is formation of pyruvate (pyr) from glucose-derived
lactate as well as extracellular lactate. Thus, extracellular lactate is only consumed during rest whereas glucose fuels the energy
needed during neuronal depolarization. This latter part is now revised in the present paper (see Figure 8). c, cytosolic; m,
mitochondrial; AGC, aspartate/glutamate carrier; Asp, aspartate; Glu, glutamate; GLUT, glucose transporter; Mal, malate; MCT,
monocarboxylate transporter; OAA, oxaloacetate; TCA, tricarboxylic acid. Reproduced with permission from: LK Bak, AB Walls, A
Schousboe, A Ring, U Sonnewald and HS Waagepetersen, Neuronal glucose but not lactate utilization is positively correlated with
NMDA-induced neurotransmission and fluctuations in cytosolic Ca
2+ levels, J Neurochem, 2009 Wiley-Blackwell. copyright 2009 The
Authors Journal Compilation copyright 2009 International Society for Neurochemistry.
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153fura-2 was lex at 340 and 380 nm and the resulting lem was
measured at 510 nm. All filters used had a bandwidth of
10 nm and the experimental temperature was 32˚C. The
results are calculated as the ratio of fluorescence from lex at
340 and 380 nm after background subtraction after 30 min
of incubation. The data represent two batches of cerebellar
neurons with 15 repetitions in total for each condition.
Metabolic experiments
Cultures of cerebellar neurons seeded in 25 cm
2 flasks were
washed twice with warm PBS (37˚C; 137 mM NaCl, 2.7 mM
KCl, 7.3 mM Na2HPO4, 1.5 mM KH2PO4, 0.9 mM CaCl2 and
0.5 mM MgCl2, pH 7.4) and incubated for 1.5 h at 37˚Ci n
serum-free culture medium containing either 2.5 mM
[U-
13C]glucose in the presence or absence of 1.0 mM
unlabelled lactate (conditions A and C respectively) or
1.0 mM [U-
13C]lactate in the presence or absence of
2.5 mM unlabelled glucose (conditions B and D respectively)
as substrates. In order to titrate [Ca
2+]i, increasing concen-
trations of ionomycin (0, 0.25, 0.50 and 0.75 mM) were
present during the last 30 min in combination with 10 mM
MK-801 and 30 mM verapamil. Some cultures were placed in
a superfusion apparatus and superfused (4 ml/min) in a
Hepes-buffered medium (5 mM Hepes, 135 mM NaCl, 5 mM
KCl, 1.8 mM CaCl2 and 2.5 mM glucose, pH 7.4, 37˚C; MK-
801 and verapamil were not present in these experiments) for
10 min at which time the medium was switched to one
containing 2.5 mM [U-
13C]glucose in place of the unlabelled
glucose and superfused for an additional 50 min. Ten 30-s
pulses (4 min intervals) of NMDA (100 mM) and glycine
(10 mM) were included in some cultures to induce
neurotransmission activity (Bak et al., 2003). The medium
was collected in fractions (12 ml corresponding to 3 min) for
determination of lactate release. After the experiments, the
cultures were extracted using 70% ethanol and the resulting
isotopic enrichment in intracellular glutamate, alanine and
lactate was determined using GC-MS.
Analytical chemistry and analysis of labelling
data
Freeze-dried cell extracts were dissolved in water and an
aliquot was dried under atmospheric air. The metabolites
were extracted into an organic phase of ethanol and benzene
and dried again before derivatization with MTBSTFA contain-
ing 1% tertbutyl-dimethylchlorosilane in DMF (dimethylfor-
mamide; Mawhinney et al., 1986). The samples were analysed
using a Shimadzu GCMS-QP2010 Plus system (Shimadzu
Corp.) equipped with a Zebron-5MS column from
Phenomenex. Percent isotopic enrichment of glutamate,
alanine and lactate was determined after correcting for
naturally abundant
13C as described by Biemann (1962).
Details on labelling of glutamate, alanine and lactate from
[U-
13C]glucose and [U-
13C]lactate are available elsewhere
(e.g. Bak et al., 2006) and the labelling in glutamate is
presented as percentage MCL (molecular carbon labelling) as
explained in Bak et al. (2006). In short, the MCL value is an
average of the percentage
13C labelling in a given metabolite.
For instance, an MCL value of 20% means that 20% of all
carbon atoms in the glutamate pool are
13C. Since incorpora-
tion of
13C into alanine arises through rapid transamination
of pyruvate and as such reflects labelling in this metabolite,
both syntheses of pyruvate from lactate and glucose contribute
to the average molecular labelling. Hence, the percentage M+3
(i.e. the
12C monoisotopic mass plus three) for alanine indicates
the direct conversion of uniformly labelled glucose or lactate
into alanine through pyruvate and is therefore presented here.
Likewise, lactate labelling should be presented as percentage
M+3. However, due to a constant contamination of the lactate
signal on the GC-MS from the derivatization reagent, the
percentage M+3 values for lactate are presented as percentage
of control within each batch of neurons.
In order to obtain information on tricarboxylic acid cycle
activity, CRs (cycling ratios) were calculated based on
labelling in glutamate according to the following formula:
([M+1]+[M+3]+[M+4]+[M+5]/[M+2]), i.e. the labelling occur-
ring in two or more turns of the tricarboxylic acid cycle
divided by the labelling occurring after the first turn (see Bak
et al., 2006 for details).
The amount of lactate released to the media during
superfusion of CCNs was quantified as previously detailed by
Lund et al. (2011). Briefly, the collected superfusion media
were freeze-dried and re-dissolved in water. Black microtitre
plates were used for conversion of lactate present in the
sample by LDH (lactate dehydrogenase). In this reaction,
NAD
+ is concomitantly reduced to NADH that can be detected
due to its autofluorescence (350 and 455 nm as lex and lem
respectively). In order for the reaction to be stoichiometric,
pyruvate formed from lactate was further transaminated to
alanine by alanine aminotransferase in the presence of
glutamate. L-Lactate was used as a standard.
The results are presented as means¡S.E.M. Data were
compared by Student’s t test or one-way ANOVA followed by
either Bonferroni (,5 groups) or Tukey–Kramer (>5 groups)
post hoc tests. A P-value of 0.05 or less was considered
statistically significant. Data were analysed employing
Microsoft Excel 2010 and GraphPad Prism 5 software.
RESULTS
Titration of intracellular Ca
2+
Ionomycin, which is commonly employed as a Ca
2+ ionophore
to elevate [Ca
2+]i (Liu and Hermann, 1978; Nicholls, 2006), was
used to titrate [Ca
2+]i in CCNs. The ratio of fura-2 fluorescence
intensity measured at 510 nm after lex at 340 and 380 nm
increased significantly in the measured range of ionomycin
concentrations (Figure 2), indicating that ionomycin may be
L. K. Bak and others
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increasing levels of [Ca
2+]i.
As discussed by Nicholls (2006), ionomycin will not only
facilitate Ca
2+ entry across the plasma membrane but also be
embedded in the inner mitochondrial membrane (and other
internal membranes) inducing Ca
2+ fluxes across the
mitochondrial inner membrane as well; this may lead to
Ca
2+ deregulation in cultured cells including cultured
neurons. However, this effect is both time- and concentra-
tion-dependent and primarily observed at ionomycin con-
centrations above 1 mM (Nicholls, 2006). Still, it should be
mentioned that even at the levels of ionomycin employed in
this study, there might be a direct effect on bioenergetics
since Ca
2+ cycling across the inner mitochondrial membrane
is linked to the proton gradient (Nicholls, 2006). The present
work demonstrates that it is possible to employ ionomycin to
dose-dependently manipulate [Ca
2+]i levels in CCNs making
ionomycin a valuable tool to study the metabolic con-
sequences of Ca
2+ signalling independent of neuronal
depolarization. It should be mentioned that both the
mitochondrial and plasma membrane potentials might be
affected by ionomycin; however, based on the work by
Nicholls (2006) we conclude that at the exposure time and
concentration of ionomycin employed in the present work,
the effects on these parameters as well as induction of Ca
2+
deregulation are minimal.
Metabolic experiments
CCNs were incubated for 1 h in the presence of [U-
13C]glucose
(2.5 mM) and lactate (1 mM; panel A in Figures 3–6);
[U-
13C]lactate and glucose (panel B), [U-
13C]glucose (panel C)
or [U-
13C]lactate (panel D) followed by 30 min in the
additional presence of increasing concentrations of ionomycin
(0, 0.25, 0.5, 0.75 mM). The resulting
13C labelling was analysed
by MS (see the Materials and methods section) in intracellular
glutamate (Figure 3), alanine (Figure 4) and lactate (Figure 5).
In the presence of unlabelled lactate, ionomycin-dependent
increases in
13C labelling from [U-
13C]glucose were observed in
glutamate, alanine and lactate (panel A in Figures 3–5
respectively). Since glutamate is in rapid equilibrium with
tricarboxylic acid cycle-derived (
13C-labelled) a-ketoglutarate
under these conditions (Berkich et al., 2005), the increase in
glutamate labelling suggests that glycolysis plus tricarboxylic
acid cycle activity is up-regulated by ionomycin. Labelling in
alanine reflects labelling in the associated pyruvate pool
derived from either glucose (via glycolysis) or lactate (via the
LDH reaction). Thus, the ionomycin-dependent increase in
alanine M+3 (Figure 4A) in combination with the increase
Figure 2 Effect of ionomycin on the intracellular Ca
2+ concentration
Cultures of cerebellar neurons were exposed to increasing concentrations of
ionomycin for 30 min and the resulting effect on the intracellular Ca
2+
concentration was measured employing the ratiometric Ca
2+ sensitive dye
fura-2. The results are displayed as the ratio of emitted light at 550 nm after
lex at 340 and 380 nm and each bar represents the means¡S.E.M. Data were
obtained from two individual batches of cerebellar neurons with 14–15
repetitions in total for each condition. a, b, c, d and e denotes differences
from 0, 0.2, 0.4, 0.6 and 0.8 mM ionomycin respectively (one-way ANOVA
followed by Tukey–Kramer post hoc test). Ionomycin dose-dependently
increases the intracellular Ca
2+ concentration.
Figure 3 Effect of ionomycin on
13C-labelling from [U-
13C]glucose and
[U-
13C]lactate into intracellular glutamate
Cultures of cerebellar neurons were incubated for 1 h with either 2.5 mM
[U-
13C]glucose in the presence or absence of 1 mM unlabelled lactate (A and
C respectively) or 1 mM [U-
13C]lactate in the presence or absence of 2.5 mM
unlabelled glucose (B and D respectively) as substrates. In order to titrate the
intracellular Ca
2+ level, increasing concentrations of ionomycin (0, 0.25, 0.50
and 0.75 mM) were present during the last 30 min of incubation in com-
bination with 10 mM MK-801 and 30 mM verapamil. The resulting
13C-
enrichment in intracellular glutamate was determined by GC-MS. The results
are displayed as percentage MCL, which is a measure of the average
13C-
labelling of a given metabolite. The data were obtained from 2 to 4 individual
batches of cerebellar neurons with 5–14 repetitions in total for each condition
and the bars represent means¡S.E.M. Significant differences (P,0.05, one-
way ANOVA followed by Bonferroni’s post hoc test) from 0 and 0.25 mM
ionomycin are indicated by a and b, respectively.
13C-Labelling from glucose
into glutamate is enhanced by ionomycin-induced increased intracellular Ca
2+
concentration both in the presence and absence of lactate (A and C
respectively). This signifies increased glycolysis and tricarboxylic acid cycle
activity since glutamate is in rapid equilibrium with the tricarboxylic acid
cycle intermediate a-ketoglutarate. In contrast,
13C-labelling from lactate is
decreased by ionomycin in the presence but not in the absence of glucose (B
and D respectively). Collectively these results indicate that extracellular lactate
is metabolized independently of Ca
2+-induced effects on glycolysis and
tricarboxylic acidcycleactivity, thelattercausingdilutionof
13C-labelling from
increased metabolism of unlabelled glucose when present.
Role of Ca
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155in [U-
13C]glucose-derived lactate M+3 (Figure 5A) reflects
increased glycolysis under these conditions. In the presence of
[U-
13C]lactate and unlabelled glucose, ionomycin-dependent
decreases in
13C-labelling were observed in glutamate
(Figure 3B) and alanine (Figure 4B), but not lactate
(Figure 5B). This suggests that extracellular lactate is metabo-
lized independently of ionomycin-induced effects on [Ca
2+]i
and glycolysis and that the decrease in labelling in glutamate
and alanine reflects increased synthesis of glucose-derived
pyruvate. In the presence of [U-
13C]glucose as the sole
substrate, the labelling in glutamate (Figure 3C) was higher
than when unlabelled lactate was present (compare with
Figure 3A). This indicates that the (labelled) pyruvate pool is
diluted by unlabelled lactate or in other words that
extracellular lactate is metabolized to a significant extent
even in the presence of glucose. Interestingly, labelling in
alanine was not affected by ionomycin (Figure 4C), which was
in contrast with lactate that showed a rather large relative
response (Figure 5C). Thus, in the presence of glucose only,
labelled lactate is being generated from a pyruvate pool in
which the labelling (via glycolytic activity) is strongly
dependent on ionomycin-induced increases in [Ca
2+]i; how-
ever, this pool is so small that it is not evident from the
labelling in the bulk pyruvate pool reflected by labelling in
alanine. When [U-
13C]lactate was the only substrate available,
labelling in both glutamate and (intracellular) lactate was not
affected by ionomycin whereas labelling in alanine showed
decreases (Figures 3D, 5D and 4D, respectively). This might
indicate that tricarboxylic acid cycle metabolism of lactate-
derived carbon is unaffected by ionomycin; however, the drop
in alanine labelling is not easily explained.
Figure 4 Effect of ionomycin on
13C-labelling from [U-
13C]glucose and
[U-
13C]lactate into intracellular alanine
Cultures of cerebellar neurons were incubated for 1 h with either 2.5 mM
[U-
13C]glucose in the presence or absence of 1 mM unlabelled lactate (A and
C respectively) or 1 mM [U-
13C]lactate in the presence or absence of 2.5 mM
unlabelled glucose (B and D respectively) as substrates. In order to titrate the
intracellular Ca
2+ level, increasing concentrations of ionomycin (0, 0.25, 0.50
and 0.75 mM) were present during the last 30 min of incubation in
combination with 10 mM MK-801 and 30 mM verapamil. The resulting
13C-
enrichment in intracellular alanine was determined by GC-MS. The results are
displayed as the
13C-enrichment of the M+3 isotopomer, i.e. alanine labelled
in all three carbon atoms that originate directly from [U-
13C]glucose- or
[U-
13C]lactate-derived pyruvate via transamination. The data were obtained
from 3 to 4 individual batches of cerebellar neurons with 5–14 repetitions in
total for each condition and the bars represent means¡S.E.M. Significant
differences (P,0.05, one-way ANOVA followed by Bonferroni’s post hoc test)
from 0 and 0.25 mM ionomycin are indicated by a and b, respectively.
13C-
labelling from glucose into alanine is enhanced by ionomycin-induced
increased intracellular Ca
2+ concentration in the presence but not the
absence of lactate (A and C respectively). Moreover, the
13C-labelling from
glucose is substantially higher in the absence than in the presence of
unlabelled lactate. Since
13C-labelling in alanine reflects that of pyruvate,
these findings indicate not only Ca
2+-induced up-regulation of glycolytic
activity but also that lactate is extensively metabolized even in unstimulated
neurons. When lactate is the labelled substrate, ionomycin brings about a
decrease in
13C-labelling in alanine in the presence of glucose (B). This might
be explained by dilution of labelling due to metabolism of unlabelled glucose,
although the corresponding decrease observed in the absence of glucose (D)
argues against this.
Figure 5 Effect of ionomycin on
13C-labelling from [U-
13C]glucose and
[U-
13C]lactate into intracellular lactate
Cultures of cerebellar neurons were incubated for 1 h with either 2.5 mM of
[U-
13C]glucose in the presence or absence of 1 mM unlabelled lactate (A and
C respectively) or 1 mM [U-
13C]lactate in the presence or absence of 2.5 mM
unlabelled glucose (B and D respectively) as substrates. In order to titrate the
intracellular Ca
2+ level, increasing concentrations of ionomycin (0, 0.25, 0.50
and 0.75 mM) were present during the last 30 min of incubation in
combination with 10 mM MK-801 and 30 mM verapamil. The resulting
13C-
enrichment in intracellular lactate was determined by GC-MS. The results are
displayed as the
13C-enrichment of the M+3 isotopomer, i.e. lactate labelled
in all three carbon atoms that originate directly from [U-
13C]glucose- or
[U-
13C]lactate-derived pyruvate via the action of LDH. In addition, the data
are expressed as percentage of control within each batch of neurons. The
data were obtained from 2 individual batches of cerebellar neurons with 4–8
repetitions in total for each condition and the bars represent means¡S.E.M.
Significant differences (P,0.05, one-way ANOVA followed by Bonferroni’s
post hoc test) from 0 and 0.25 mM ionomycin are indicated by a and b,
respectively.
13C-Labelling from glucose into lactate is enhanced by
ionomycin-induced increased intracellular Ca
2+ concentration both in the
presence and absence of extracellular lactate (A and C respectively). This
signifies increased glycolytic activity since labelling in lactate reflects that of
pyruvate. In contrast, ionomycin has no effect on
13C-labelling of intracellular
lactate from the extracellular pool of the same metabolite (B and D).
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cycle activity under the experimental conditions employed,
we calculated the CRs for each experimental condition (see
the Materials and methods section and Bak et al. (2006) for
details). The CR in the presence of [U-
13C]glucose and
unlabelled lactate increased significantly as a consequence of
treatment with ionomycin (Figure 6A), whereas no effect
of ionomycin was evident when lactate was the labelled
substrate in the presence of unlabelled glucose (Figure 6B)
except for a small but significant increase in the presence of
0.25 mM ionomycin. When only [U-
13C]glucose or
[U-
13C]lactate was present, the CRs were higher compared
with when both substrates were present (compare panels C
and D to A and B in Figure 6); however, ionomycin-
dependent increases were only evident when [U-
13C]glucose
but not when [U-
13C ] l a c t a t ew a st h es o l es u b s t r a t e
(Figures 6C and 6D respectively). Collectively, this indicates
metabolic compartmentation and that the tricarboxylic acid
cycle metabolizing glucose-derived carbon increases cycling
activity whereas the tricarboxylic acid cycle that metabolizes
lactate-derived carbon operates at a constant level of activity
independent of the metabolic response to the ionomycin-
induced increase in [Ca
2+]i.
In a separate experiment, CCNs were superfused in the
presence of 2.5 mM glucose (no lactate) and subjected to
pulses of NMDA (100 mM; plus 10 mM glycine) to induce
Ca
2+-dependent neurotransmission activity as previously
described (see the Materials and methods and Bak et al.,
2003; 2009 for further details). The superfusion medium was
collected in fractions and the release of lactate was
quantified by measuring the content of lactate in these
fractions. The release (nmol?min
21?mg
21 of protein) was
significantly increased when the cultures were subjected to
pulses of NMDA (Figure 7), indicating increased anaerobic
glycolysis.
DISCUSSION
We show here that neuronal glucose utilization is increased by
an ionomycin-dependent increase in [Ca
2+]i,m i m i c k i n g
neuronal Ca
2+ signalling, whereas utilization of extracellular
lactate is prominent but not significantly affected by Ca
2+
signalling; these observations are in line with the CiMASH
model (Figure 1) and furthermore suggestive of compartmen-
talized glucose and lactate metabolism. We present a revised
CiMASH model in which metabolic compartmentation is
taken into account, dividing the neuron into two metabolic
compartments: a presynaptic compartment metaboliz-
ing glucose and a postsynaptic compartment metabolizing
both glucose and lactate.
Figure 6 Effect of ionomycin on tricarboxylic acid cycle activity
Cultures of cerebellar neurons were incubated for 1 h with either 2.5 mM
[U-
13C]glucose in the presence or absence of 1 mM unlabelled lactate (A and
C respectively) or 1 mM [U-
13C]lactate in the presence or absence of 2.5 mM
unlabelled glucose (B and D respectively) as substrates. In order to titrate the
intracellular Ca
2+ level, increasing concentrations of ionomycin (0, 0.25, 0.50
and 0.75 mM) were present during the last 30 min of incubation in
combination with 10 mM MK-801 and 30 mM verapamil. The resulting
13C-
enrichment in intracellular glutamate was determined by GC-MS. Based on
the isotopomeric
13C-labelling of glutamate, the CR, which is a measure
of the activity of the tricarboxylic acid cycle, was calculated as described in
the Materials and Methods section. The data were obtained from 2 to 4
individual batches of cerebellar neurons with 5–14 repetitions in total for
each condition and the bars represent means¡S.E.M. Significant differences
(P,0.05, one-way ANOVA followed by Bonferroni’s post hoc test) from 0 to
0.25 mM ionomycin are indicated by a and b, respectively. Irrespective of the
presence of extracellular lactate, the rate of [U-
13C]glucose metabolism in
the tricarboxylic acid cycle increases with increasing ionomycin-induced
intracellular Ca
2+ levels (A and C). However, with the exception of 0.25 mM
ionomycin in the presence of glucose, the metabolism of lactate through the
tricarboxylic acid cycle is unaffected by ionomycin (B and D).
Figure 7 NMDA-induced release of lactate from CCNs during superfusion
in the presence of 2.5 mM glucose
CCNs were superfused (2 ml/min) in a Hepes-buffered medium containing
glucose (2.5 mM) as substrate and subjected to 30-s pulses consisting of
NMDA (100 mM) and glycine (10 mM). The rate of lactate release was
quantified as described in the Materials and methods section and expressed
as nmol of lactate released per min per mg of protein. a; significantly
different from the control (i.e. no NMDA pulses) as determined employing
Student’s t test (P,0.05).
Role of Ca
2+ signalling in neuronal bioenergetics
E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.
157Ca
2+-dependent regulation of glucose and
lactate utilization
The observation that glucose utilization increases and lactate
utilization decreases as a consequence of the presence of
ionomycin (Figures 3A and 3B) mimics the previous findings
that neuronal glycolysis and subsequent tricarboxylic acid
cycle metabolism are up-regulated during NMDA-induced
activation (Bak et al., 2006) and that consumption of glucose
but not lactate correlates with neurotransmission activity
(Bak et al., 2009). Here, we support and extend the earlier
findings by demonstrating that the effects on metabolism
previously reported as a consequence of NMDA receptor
stimulation are mirrored by an ionomycin-induced increase in
[Ca
2+]i.
13C-Labelling in lactate when [U-
13C]glucose is the sole
substrate reflects labelling in glycolysis-generated pyruvate
that is transformed into lactate by the reversible LDH-
catalysed reaction. Thus, an increased labelling in lactate per
se may not reflect net lactate production but simply
increased glycolytic activity. However, comparing labelling
from [U-
13C]glucose into glutamate, lactate and alanine it is
apparent that the relative increase in lactate labelling
is greater for all ionomycin concentrations than the
corresponding glutamate and alanine labelling in the pre-
sence of extracellular lactate. This clearly demonstrates that
anaerobic glycolysis is amplified by ionomycin, resulting in
net lactate production. That increased lactate production and
release is indeed taking place in these cultures during
neurotransmission activity is evident from the increase in the
rate of lactate release when the cultures were subjected to
pulses of NMDA (Figure 7).
In contrast to the labelling in lactate derived from
[U-
13C]glucose, labelling from extracellular [U-
13C]lactate
into intracellular lactate was unaffected by ionomycin
(Figures 5B and 5D). Since the transfer of lactate between
the intra- and extra-cellular environments is primarily
controlled by the concentration gradient across the plasma
membrane one would expect a decrease in uptake of
extracellular lactate when glucose is present due to
production of glucose-derived lactate and, hence,
decreased labelling with increasing [Ca
2+]i. However, taken
together with the increase in lactate labelled from
[U-
13C]glucose, these data indicate a compartmentalization
of the lactate produced from glucose and the extracellular
lactate pool where the former is preferentially transport-
ed out of the cell independently of the import and utiliza-
tion of the latter. Seemingly opposing this conclusion is
ad e c r e a s ei n
13C enrichment from extracellular [U-
13C]-
lactate into glutamate and alanine observed when unla-
belled glucose is present (Figures 3B and 4B). However, the
decreased labelling in glutamate (Figure 3B) is probably due
to dilution of labelling in the acetyl-CoA pool as a
Figure 8 A compartmentalized CiMASH model for glutamatergic neurons
In the compartmentalized model, the CiMASH mechanism is working in the postsynaptic compartment in which NMDA-receptor-
mediated Ca
2+-induced Ca
2+ release from the endoplasmic reticulum (ER) directly signals to a subset of postsynaptic mitochondria
(type B) that increase their tricarboxylic acid cycle activity driven by breakdown of glucose-derived pyruvate (pyr). Notice that
glucose-derived pyruvate is only in partial equilibrium with lactate (Lac)-generated pyruvate. When the CiMASH mechanism is
activated, glucose-derived lactate is produced and released to the extracellular space for oxidation at a later time point. Pyruvate
derived from extracellular lactate is metabolized in a mitochondrial compartment that is not affected by postsynaptic Ca
2+ signalling
(type A). At the presynaptic compartment, the voltage-gated Ca
2+ channel (VGCC)-activated ER-to-mitochondria Ca
2+-signalling will
affect mitochondrial tricarboxylic acid cycle metabolism (type C) of glucose-derived pyruvate and activate the CiMASH mechanism
to some extent; the lactate generated in this compartment is not able to leave the cell due to lack of transporters. It should be noted
that substrate-level phosphorylation in the glycolytic pathway probably plays a functionally important role at the presynaptic
terminal (not shown here).
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which is also supported by the unaltered labelling from
[U-
13C]lactate into glutamate when glucose is absent
(Figure 5D). The reduced labelling in alanine (Figure 4B) is
possibly due to pyruvate being increasingly transported into
the mitochondria to support augmented tricarboxylic acid
cycling; this would likely occur at the expense of alanine
production, as in fact seems to be the case (Figure 4D).
Furthermore, a reduced alanine production would entail
an even more pronounced decrease in alanine labelling
from extracellular [U-
13C]lactate compared with labell-
ing in glutamate, which is also apparent from the present
experiments (compare Figures 3D and 4D). However,
dilution of labelling due to the presence of glucose
cannot explain the decrease in
13C incorporation into
alanine from [U-
13C]lactate observed when glucose is
absent (Figure 4D). This decrease might be due to a
reduced production of alanine combined with an increase
in pyruvate recycling activity initiated as a rescue
operation to keep tricarboxylic acid cycling going at the
expense of tricarboxylic acid cycle intermediates (Olstad
et al., 2007); if this is indeed the case, it clearly signifies
that glucose is needed to sustain energy metabolism
during Ca
2+-induced activation.
From the above considerations, one might envisage a
scenario in which two pools of mitochondria exist at the
postsynaptic region, one primarily but not exclusively
metabolizing extracellular lactate-derived carbon
(denoted type A in Figure 8) and one metabolizing
glucose-derived carbon including glucose-derived lactate
(type B); type A is insensitive whereas type B is sensitive to
fluctuations in [Ca
2+]i. This might be caused by the fact
that for mitochondria to be sensitive to Ca
2+ signalling,
they have to be closely associated with the endoplasmic
reticulum (Franzini-Armstrong, 2007); thus, a pool of
postsynaptic mitochondria may not be closely associated
with the endoplasmic reticulum, likely reflecting a mobile
or moving fraction of mitochondria (MacAskill et al.,
2010). It has been suggested that presynaptic terminals
contain no MCTs (monocarboxylate transporters) neces-
s a r yf o ri m p o r ta n de x p o r to fl a c t a t e( B e r g e r s e ne ta l . ,
2005). Thus, presynaptic terminals may be fuelled only by
oxidative glycolysis (the pyruvate generated is oxidized in
the type C mitochondrial compartment in Figure 8) and
glycolytically produced ATP (substrate-level phosphoryla-
tion) may play an important role in providing energy for
presynaptic glutamate uptake and vesicular filling
(Ikemoto et al., 2003; Bak et al., 2006; Schousboe et al.,
2011).
A model of compartmentalized, Ca
2+-dependent
neuronal bioenergetics
The above considerations may lead to a revised model, in
which the CiMASH mechanism is primarily operating in the
postsynaptic compartment (Figure 8). In this model,
the following sequence of events may take place during
neurotransmission activity. Upon depolarization, the presy-
naptic terminal will consume glycolytic energy producing an
intracellular store of lactate (presuming they have no MCTs)
for later oxidation; this is caused by the idea that the
immediate need for ATP for vesicular filling and in particular
presynaptic glutamate uptake is produced by glycolysis, not
mitochondrial oxidative metabolism (cf. above). At the
postsynaptic end, NMDA-induced depolarization and
the associated spike in [Ca
2+]i induce the CiMASH mechanism,
resulting in anaerobic glycolysis and lactate production, a
fraction of which will be released to the extracellular
environment and serve as an extracellular fuel reservoir; the
latter may be in accordance with the ‘reverse’ lactate shuttle
suggested by Mangia et al. (2009) as well as the suggestion by
Gandhi et al. (2009) of astrocytic uptake of lactate, subsequent
dispersion via the astrocytic syncytium and eventual discharge
in a different location. In the type B mitochondrial
compartment, increased cycling activity results in increased
utilization of acetyl-CoA derived from glucose, whereas in the
type A mitochondrial compartment, metabolism of lactate-
derived acetyl-CoA will remain constant. Upon neuronal re-
polarization, the neuronal utilization of the lactate produced
during the depolarization event will increase due to the
normalization of the MASH activity. During intense neuronal
firing, the CiMASH mechanism would be even more
pronounced, since fluctuations in the intramitochondrial
[Ca
2+] may not keep up with the rapid cytosolic spiking and
mitochondria will accumulate Ca
2+ and maintain an elevated
intramitochondrial [Ca
2+] for a longer period of time (Kaftan
et al., 2000). As a final note, it is clear from the above dis-
cussion that the model reflects not only data presented in this
manuscriptbutincludes work from a number of laboratories as
well as some aspects that are somewhat speculative. The task is
nowtotestand ifnecessarymodifythemodelbasedonboth in
vitro and eventually in vivo experiments.
Conclusion
The interpretation of the data presented in this paper lends
further support to the CiMASH model and, furthermore leads
to a model in which the CiMASH mechanism is operating at
the postsynaptic compartment. Current studies are directed
towards elucidating the second-messenger signalling path-
ways involved and establishing the subcellular localization of
the CiMASH mechanism including postsynaptic mitochondrial
dynamics.
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